Skip to main content
DXCM
NASDAQ Life Sciences

DexCom Posts $275.1M Third-Quarter Net Income

Tom Rudovsky · Reported by Dow Jones Newswires
More coverage: Medical Device Stocks · Healthcare
Sentiment info
Positive
Importance info
7
Price
$79.93
Mkt Cap
$30.162B
52W Low
$54.11
52W High
$92.59
52W Position info
48% above low
Off High info
14% below high
Rel. Volume info
1.2× avg
Market data snapshot near publication time

DXCM sits 48% above its 52-week low of $54.11.

Summary

DexCom reported third-quarter net income of $275.1 million, with revenue of $1.34 billion, up 11% year over year, and EPS of 72 cents. The company raised its 2026 revenue guidance to $5.20-$5.25 billion (12-13% growth), with non-GAAP operating margin about 24% and adjusted EBITDA margin about 32%, and authorized a $1 billion buyback. The result lands after a positive stretch for the stock, including the October 15 CONNECT trial publication in the New England Journal of Medicine showing the G7 CGM cut A1C.

Updated with an SEC 8-K filing · What changed

Updates

  1. · SEC 8-K — Dexcom raised 2026 revenue guidance to $5.20-$5.25 billion (12-13% growth), with non-GAAP operating margin about 24% and adjusted EBITDA margin about 32%.

At the time of this announcement, DXCM was trading at $79.93 on NASDAQ in the Life Sciences sector, with a market capitalization of approximately $30.2B. The 52-week trading range was $54.11 to $92.59. This news item was assessed with positive market sentiment and an importance score of 7 out of 10. Source: Dow Jones Newswires.


Price Chart

Share this article

Copied!

DXCM - Latest Insights

DXCM
Oct 29, 2026, 5:22 PM EDT
Filing Type: 10-Q
Importance Score:
7
Price at Filing: $81.30
Real-time Price: $83.31 info
Change: +$2.01 (+2%) info
Market Cap: $31.078B info
DXCM
Oct 29, 2026, 4:03 PM EDT
Filing Type: 8-K
Importance Score:
7
Price at Filing: $79.20
Real-time Price: $83.31 info
Change: +$4.11 (+5%) info
Market Cap: $31.078B info
DXCM
Oct 15, 2026, 10:04 AM EDT
Source: Seeking Alpha
Importance Score:
7
Price at Filing: $87.85
Real-time Price: $83.31 info
Change: -$4.54 (-5%) info
Market Cap: $31.078B info
DXCM
Jul 30, 2026, 5:21 PM EDT
Filing Type: 10-Q
Importance Score:
9
Price at Filing: $80.39
Real-time Price: $83.31 info
Change: +$2.92 (+4%) info
Market Cap: $31.078B info
DXCM
Jul 30, 2026, 4:03 PM EDT
Filing Type: 8-K
Importance Score:
9
Price at Filing: $79.00
Real-time Price: $83.31 info
Change: +$4.31 (+5%) info
Market Cap: $31.078B info